Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000030

Chief Executive Officer gave up 3,673 shares (to pay taxes)

  • Chief Executive Officer acquired 12,379 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-13 Exercise or conversion : show line 1 in the form +12,379 54,101 D
2020-04-14 Shares withheld for taxes : show line 2 in the form −3,673 $40.64 $149,271 50,428 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-13 Exercise or conversion : show line 3 in the form Performance share units −12,379 24,759 D
Loading xslF345X03/wf-form4_158698236240236.xml…